Annual SG&A:
$99.74M+$41.64M(+71.68%)Summary
- As of today, CRNX annual SG&A is $99.74 million, with the most recent change of +$41.64 million (+71.68%) on December 31, 2024.
- During the last 3 years, CRNX annual SG&A has risen by +$75.21 million (+306.67%).
- CRNX annual SG&A is now at all-time high.
Performance
CRNX SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$49.84M+$14.32M(+40.30%)Summary
- As of today, CRNX quarterly SG&A is $49.84 million, with the most recent change of +$14.32 million (+40.30%) on June 30, 2025.
- Over the past year, CRNX quarterly SG&A has increased by +$25.00 million (+100.67%).
- CRNX quarterly SG&A is now at all-time high.
Performance
CRNX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$4.04B-$369.83M(-10.08%)Summary
- As of today, CRNX TTM SG&A is -$4.04 billion, with the most recent change of -$369.83 million (-10.08%) on June 30, 2025.
- Over the past year, CRNX TTM SG&A has dropped by -$4.12 billion (-5260.59%).
- CRNX TTM SG&A is now -24720.35% below its all-time high of -$16.27 million.
Performance
CRNX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
CRNX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +71.7% | +100.7% | -5260.6% |
| 3Y3 Years | +306.7% | +375.2% | -10000.0% |
| 5Y5 Years | +637.8% | +1053.2% | -10000.0% |
CRNX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +306.7% | at high | +342.1% | -203.2% | at low |
| 5Y | 5-Year | at high | +637.8% | at high | +948.9% | -743.5% | at low |
| All-Time | All-Time | at high | +6406.0% | at high | >+9999.0% | >-9999.0% | at low |
CRNX Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $49.84M(+40.3%) | $139.44M(+21.8%) |
| Mar 2025 | - | $35.53M(+26.1%) | $114.44M(+14.7%) |
| Dec 2024 | $99.74M(+71.7%) | $28.18M(+8.8%) | $99.74M(+12.5%) |
| Sep 2024 | - | $25.89M(+4.2%) | $88.64M(+13.3%) |
| Jun 2024 | - | $24.84M(+19.3%) | $78.23M(+17.2%) |
| Mar 2024 | - | $20.83M(+22.0%) | $66.73M(+14.9%) |
| Dec 2023 | $58.09M(+37.0%) | $17.08M(+10.3%) | $58.09M(+11.1%) |
| Sep 2023 | - | $15.48M(+16.0%) | $52.29M(+7.3%) |
| Jun 2023 | - | $13.34M(+9.5%) | $48.73M(+6.2%) |
| Mar 2023 | - | $12.19M(+8.1%) | $45.88M(+8.2%) |
| Dec 2022 | $42.39M(+72.9%) | $11.27M(-5.5%) | $42.39M(+10.2%) |
| Sep 2022 | - | $11.93M(+13.7%) | $38.48M(+17.4%) |
| Jun 2022 | - | $10.49M(+20.5%) | $32.78M(+17.5%) |
| Mar 2022 | - | $8.71M(+18.3%) | $27.90M(+13.7%) |
| Dec 2021 | $24.52M | $7.36M(+18.2%) | $24.52M(+10.9%) |
| Sep 2021 | - | $6.23M(+11.2%) | $22.12M(+7.1%) |
| Jun 2021 | - | $5.60M(+5.0%) | $20.65M(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $5.33M(+7.5%) | $19.37M(+7.5%) |
| Dec 2020 | $18.03M(+33.3%) | $4.96M(+4.4%) | $18.03M(+9.5%) |
| Sep 2020 | - | $4.75M(+9.9%) | $16.46M(+5.4%) |
| Jun 2020 | - | $4.32M(+8.3%) | $15.62M(+8.8%) |
| Mar 2020 | - | $3.99M(+17.7%) | $14.35M(+6.2%) |
| Dec 2019 | $13.52M(+103.0%) | $3.39M(-13.3%) | $13.52M(+6.5%) |
| Sep 2019 | - | $3.91M(+27.8%) | $12.69M(+20.7%) |
| Jun 2019 | - | $3.06M(-3.0%) | $10.51M(+22.7%) |
| Mar 2019 | - | $3.16M(+23.2%) | $8.57M(+28.7%) |
| Dec 2018 | $6.66M(+243.4%) | $2.56M(+47.9%) | $6.66M(+45.9%) |
| Sep 2018 | - | $1.73M(+54.9%) | $4.57M(+37.3%) |
| Jun 2018 | - | $1.12M(-10.4%) | $3.32M(+50.7%) |
| Mar 2018 | - | $1.25M(+167.2%) | $2.21M(+42.6%) |
| Dec 2017 | $1.94M(+26.5%) | $467.00K(-4.9%) | $1.55M(+43.2%) |
| Sep 2017 | - | $491.00K(-16.6%) | $1.08M(+83.4%) |
| Mar 2017 | - | $589.00K | $589.00K |
| Dec 2016 | $1.53M | - | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual SG&A?
- What is the all-time high annual SG&A for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual SG&A year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. TTM SG&A year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual SG&A?
The current annual SG&A of CRNX is $99.74M
What is the all-time high annual SG&A for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual SG&A is $99.74M
What is Crinetics Pharmaceuticals, Inc. annual SG&A year-on-year change?
Over the past year, CRNX annual SG&A has changed by +$41.64M (+71.68%)
What is Crinetics Pharmaceuticals, Inc. quarterly SG&A?
The current quarterly SG&A of CRNX is $49.84M
What is the all-time high quarterly SG&A for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly SG&A is $49.84M
What is Crinetics Pharmaceuticals, Inc. quarterly SG&A year-on-year change?
Over the past year, CRNX quarterly SG&A has changed by +$25.00M (+100.67%)
What is Crinetics Pharmaceuticals, Inc. TTM SG&A?
The current TTM SG&A of CRNX is -$4.04B
What is the all-time high TTM SG&A for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high TTM SG&A is -$16.27M
What is Crinetics Pharmaceuticals, Inc. TTM SG&A year-on-year change?
Over the past year, CRNX TTM SG&A has changed by -$4.12B (-5260.59%)